【摘 要】
：
Background Patients with acute myocardial infarction (AMI) with unprotected left main coronary artery (UPLMCA) as culprit lesion are a high-risk subgroup with a substantial mortality.Primary percutane
【机 构】
：
Zhong Shan Hospital,Fudan University,Shanghai,China
【出 处】
：
第十二届中国介入心脏病学大会(CIT2014)
论文部分内容阅读
Background Patients with acute myocardial infarction (AMI) with unprotected left main coronary artery (UPLMCA) as culprit lesion are a high-risk subgroup with a substantial mortality.Primary percutaneous coronary intervention (PCI) has become the standard treatment for patients presenting with AMI including those with left main occlusion.However,limited data is available on patients with UPLMCA disease presenting with AMI.Therefore,we analyzed the clinical characteristics and the short-and long-term outcomes of patients undergoing emergency PCI for AMI due to UPLMCA lesion.
其他文献
Background Bifurcation lesions double stenting whether or not to complete the kiss expansion directly influences the prognosis,the final kissing rate of classical CRUSH technique is low,DK crush techn
Background It remains unclear whether intracoronary (IC) or intravenous (Ⅳ) administration of Tirofiban is superior for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary int
Background MicroRNA (miRNA) is a newly discovered endogenous non-coding single stranded RNAs,composed of 20-23 nucleotides,plays an important role in regulating in the process of cell differentiation,
Background Higher rates of adverse cardiac events and restenosis have been observed in patients with small vessel disease.The workhorse sizes of FIREHAWK abluminal groove-filled biodegradable polymer
Background Long coronary lesions remain a higher risk of unfavorable outcomes after percutaneous coronary intervention and the stent length was recognized an independent factor for DES failure.No larg
Background The choice of revascularization strategy in multivessel coronary disease remains a critical issue in cardiology.No large-scale clinical study of everolimus-eluting Stents (EES) was conducte
Background Scant data exist regarding the impact of diabetes mellitus (DM) status on percutaneous coronary intervention (PCI) for left main (LM) coronary artery disease.We sought to compare the impact
Background TARGET Ⅰ randomized controlled trial (RCT) demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was
目的 评价富马酸喹硫平600 ～ 750mg/d单药治疗精神分裂症急性期兴奋症状的疗效和安全性.方法 采用前瞻性、单组、开放性的设计,纳入符合ICD-10诊断标准的精神分裂症急性期患者124例,予喹硫平600～750mg/d单药治疗.观察时间为24周,在基线、治疗第1周末、第8周末及第24周末评估患者的治疗效果及安全性.疗效指标为阳性与阴性症状综合症量表(positive and negative
目的 评价富马酸喹硫平单药治疗精神分裂症急性期阴性症状和抑郁症状的疗效.方法 采用前瞻性、单组、开放性的研究设计.纳入符合ICD-10精神分裂症诊断标准的124例精神分裂症急性期住院患者,予富马酸喹硫平600～750mg/d单药治疗,观察时间为24周,在基线、治疗第1周末、第8周末及第24周末评估患者的治疗效果及安全性.疗效指标为阳性与阴性症状综合征量表(PANSS)评分变化、蒙哥马利抑郁量表(M